propranolol has been researched along with Somatoform Disorders in 3 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Somatoform Disorders: Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by another medical condition, by the direct effects of a substance, or by another mental disorder. The MEDICALLY UNEXPLAINED SYMPTOMS must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The prognosis of treated hypochondriasis is good in a substantial proportion of patients." | 1.27 | Functional somatic symptoms and hypochondriasis. A survey of empirical studies. ( Kellner, R, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Brignardello-Petersen, R | 1 |
| Dominguez, RA | 1 |
| Goldstein, BJ | 1 |
| Kellner, R | 1 |
1 trial available for propranolol and Somatoform Disorders
| Article | Year |
|---|---|
Beta-blockers in psychiatry.
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trial | 1984 |
2 other studies available for propranolol and Somatoform Disorders
| Article | Year |
|---|---|
Patients with temporomandibular pain who receive propranolol are more likely to experience pain reduction than those who receive a placebo.
Topics: Humans; Pain; Propranolol; Somatoform Disorders; Temporomandibular Joint Disorders | 2020 |
Functional somatic symptoms and hypochondriasis. A survey of empirical studies.
Topics: Anti-Anxiety Agents; Attitude to Health; Benzodiazepines; Conditioning, Psychological; Culture; Diag | 1985 |